Droga, alcol e lavoro: La prevenzione come promozione della salute

Lo scopo di questa dissertazione è quello di costruire un modello di promozione della salute nel contesto di lavoro in relazione al consumo di sostanze psicoattive fra lavoratori, attraverso il confronto tra la situazione italiana e inglese. L’ipotesi di fondo rimanda all’idea che i luoghi di lavoro possano rappresentare setting d’elezione per i progetti di prevenzione non solo perché alcuni studi dimostrano l’esistenza di fattori di rischio connessi alla mansione rispetto alle condotte relative allo stile di vita, ma anche perché il consumo di alcol e droghe è altamente diffuso tra i lavoratori e questo comporta rischi per la sicurezza e la salute personale nonché quella dei colleghi di lavoro. Si tratta quindi di indagare il rapporto tra contesto lavorativo e utilizzo di sostanze al fine di suggerire  alla luce degli studi internazionali in materia e delle riflessioni condotte dai soggetti coinvolti nella ricerca che si andrà a presentare  linee guida e indicazioni operative per la realizzazione di interventi di promozione alla salute nei contesti professionali. A tal fine, saranno analizzati gli esiti di 13 focus group che hanno coinvolto esperti italiani e 6 interviste somministrate a esperti inglesi volti a definire la situazione attuale in Italia e Gran Bretagna in materia di prevenzione del consumo di alcol e droghe nei luoghi di lavoro. In particolare, l’analisi verterà sulle seguenti aree: - Percezione circa la diffusione dei consumi nei luoghi di lavoro - Presentazione delle politiche adottate, in logica comparativa, tra i due paesi. - Analisi critica degli interventi e problematiche aperte. L’analisi del materiale empirico permette di delineare due modelli costruiti sulla base dei focus group e delle interviste: - in Italia si può affermare che prevalga il cd. modello della sicurezza: di recente trasformazione, questo sistema enfatizza la dimensione del controllo, tanto che si parla di sorveglianza sanitaria. É orientato alla sicurezza concepita quale rimozione dei fattori di rischio. Il consumo di sostanze (anche sporadico) è inteso quale espressione di una patologia che richiede l’intervento sanitario secondo modalità previste dal quadro normativo: una procedura che annulla la discrezionalità sia del datore di lavoro sia del medico competente. Si connota inoltre per contraddizioni interne e trasversali rispetto alle categorie lavorative (i controlli non si applicano alle professioni associate a maggiore prestigio sociale sebbene palesemente associate a rischio, come per esempio i medici) e alle sostanze (atteggiamento repressivo soprattutto verso le droghe illegali); - in Gran Bretagna, invece, il modello si configura come responsabilità bilaterale: secondo questo modello, se è vero che il datore di lavoro può decidere in merito all’attuazione di misure preventive in materia di alcol e droghe nei luoghi di lavoro, egli è ritenuto responsabile della mancata vigilanza. D’altro canto, il lavoratore che non rispetta quanto previsto nella politica scritta può essere soggetto a licenziamento per motivi disciplinari. Questo modello, particolarmente attento al consumo di tutte le sostanze psicoattive (legali e illegali), considera il consumo quale esito di una libera scelta individuale attraverso la quale il lavoratore decide di consumare alcol e droghe così come decide di dedicarsi ad altre condotte a rischio. Si propone di ri-orientare le strategie analizzate nei due paesi europei presi in esame attraverso la realizzazione di un modello della promozione della salute fondato su alcuni punti chiave: – coinvolgimento di tutti i lavoratori (e non solo coloro che svolgono mansioni a rischio per la sicurezza) al fine di promuovere benessere secondo un approccio olistico di salute, orientato ad intervenire non soltanto in materia di consumo di sostanze psicoattive (legali e illegali), ma più in generale sulle condotte a rischio; – compartecipazione nelle diverse fasi (programmazione, realizzazione e valutazione del progetto) del lavoratore, datore di lavoro e medico competente secondo una logica di flessibilità, responsabilizzazione condivisa fra i diversi attori, personalizzazione e co-gestione dell’intervento; – azione volta a promuovere i fattori di protezione agendo simultaneamente sul contrasto dei fattori di rischio (stress, alienazione, scarso riconoscimento del ruolo svolto), attraverso interventi che integrano diverse strategie operative alla luce delle evidenze scientifiche (Evidence-Based Prevention); – ricorso a strumenti di controllo (drug testing) subordinato all’esigenza di tutelare l’incolumità fisica del lavoratore e dei colleghi, da attuarsi sempre e comunque attraverso prassi che non violino la privacy e attraverso strumenti in grado di verificare l’effettivo stato di alterazione psico-fisica sul luogo di lavoro; – demedicalizzazione delle situazioni di consumo che non richiedono un intervento prettamente sanitario, ma che al contrario potrebbero essere affrontate attraverso azioni incentrate sul care anziché la cure; – messa a disposizione di servizi ad hoc con funzione di supporto, counselling, orientamento per i lavoratori, non stigmatizzanti e con operatori di formazione non solamente sanitaria, sull’esempio degli EAPs (Employee Assistence Programs) statunitensi. Si ritiene che questo modello possa trasformare i contesti di lavoro da agenzie di controllo orientate alla sicurezza a luoghi di intervento orientati al benessere attraverso un’azione sinergica e congiunta volta a promuovere i fattori di protezione a discapito di quelli di rischio in modo tale da intervenire non soltanto sul consumo di sostanze psicotrope, ma più in generale sullo stile di vita che influenza la salute complessiva.

L’istituto della riabilitazione tra cancellazione del reato e riparazione alla vittima: la sua applicazione nelle realtà europee italiana e belga

La realizzazione di questa ricerca ha come obiettivo principe lo studio approfondito dell’istituto della riabilitazione penale all’interno del panorama legislativo italiano, con riferimento al contesto bolognese, e nella legislazione belga; inoltre si pone come scopo l’analisi dell’interazione autore-vittima del reato, con una particolare attenzione al risarcimento elargito alla persona offesa dal reato e alla figura della vittima prima nel sistema penale, poi nel procedimento specifico che porta alla riabilitazione del condannato. Il punto di partenza del lavoro di ricerca intrapreso è costituito da un’accurata ricerca bibliografica inerente agli argomenti trattati, al fine di poter approfondire una buona parte della letteratura italiana e belga esistente in materia. La fase successiva della ricerca è stata quella di reperire informazioni riguardanti l’ambito di studio da approfondire, cioè la riabilitazione, secondo una direttrice empirica. Pertanto, per quanto concerne la realtà italiana, sono stati analizzati, tramite una griglia di rilevazione costruita ad hoc, i fascicoli processuali relativi alla riabilitazione presenti negli archivi del Tribunale di Sorveglianza di Bologna (2004-2009); la situazione belga è invece stata studiata reperendo dati, riferiti alla réhabilitation pénal, rintracciati presso il “Service Public Fédéral Justice - Bureau Permanent Statistiques et Mesure de la charge de travail (BPSM)” (2008-2009), sia livello nazionale che delle cinque Corti di appello. Inoltre, al fine di ottenere un ulteriore punto di vista empirico riguardante l’istituto della riabilitazione penale, sono state effettuate delle interviste semi-strutturate al Presidente del Tribunale di Sorveglianza Dott. Francesco Maisto e al Sostituto Procuratore Generale di Liège Mr. Nicolas Banneux. Infatti l’esperienza lavorativa e il particolare ruolo ricoperto da questi “osservatori privilegiati”, competenti di riabilitazione e particolarmente sensibili alle tematiche criminologiche e vittimologiche, li pone direttamente in contatto con l’istituto e la procedura della riabilitazione, determinando in loro una profonda padronanza dell’oggetto di ricerca.

Tumori misti epatocolangiocellulari su cirrosi: Aspetti diagnostici e caratteristiche clinico-demografiche

Nel tumore combinato epatocolangiocellulare (CHC) le componenti epatocitarie e colangiocitarie sono entrambe presenti. Obiettivo: valutare gli aspetti diagnostici radiologici e caratteristiche clinico-demografiche del CHC su cirrosi. Raccolti pazienti con CHC su cirrosi afferenti a due centri del Nord Italia (Bologna, S. Orsola-Malpighi e Milano,IRCCS Ca’ Granda Maggiore Hospital) tra 2003-2013, con diagnosi istologica di CHC. FASE 1:confronto tra ecografia con mdc (CEUS), TC cmdc e RM cmdc nella diagnosi e caratterizzazione dei noduli di CHC. Casistica di 35 pazienti e 37 noduli (due recidive CHC incluse). Mediana delle dimensioni: 25 mm. Non si è identificato un pattern contrastografico patognomonico per CHC. Pattern di enhancement arterioso ad anello periferico, suggestivo per forma colangiocitaria, atipico per HCC, presente nel 26%,50%,29% dei noduli a CEUS,TC,RM. La CEUS avrebbe portato a una errata diagnosi di HCC tipico in un numero maggiore di casi (48%) vs TC(15%,p=0.005), e RM(18%,p=0.080).L’indicazione della malignità del nodulo (presenza di wash-out dopo enhancement arterioso), era fornita con maggiore accuratezza da parte della CEUS(78%), vs TC (24%,p<0.0001) e RM(29%,p=0.002). FASE 2:analisi degli aspetti clinico-laboratoristici e prognostici del CHC e confronto tramite match 1:2 con HCC su cirrosi (36 CHC,72 HCC). Nel CHC correlano positivamente con sopravvivenza le terapie “curative” (trapianto, resezione chirurgica, terapie ablative percutanee a radiofrequenza/ alcolizzazione), stadio precoce alla diagnosi, dimensioni e essere in sorveglianza per diagnosi precoce di HCC. Correlano indipendentemente con sopravvivenza stadio precoce di malattia (unifocale, ≤ 2 cm) e essere in programma di sorveglianza(multivariata). Sopravvivenze del CHC sovrapponibili al gruppo HCC a 1 anno, e lievemente inferiori a 3/5 anni (81%, 39%, 21% vs 83%, 59% e 40%,p=0.78,p=0.080 e p=0.14). Sopravvivenza mediana per CHC (2.36 anni) inferiore vs HCC (4.09 anni) pur senza significatività statistica.

Evaluation of antimutagenic activity and mechanisms of action of beta-glucan from barley, in CHO-k1 and HTC cell lines using the micronucleus test

Due to the need to identify new antimutagenic agents and to determine their mechanism of action, the present study examined the mechanism of action of the P-glucan with regard to antimutagenicity using the micronucleus assay in CHO-kl and HTC cell lines. The mutagenicity experiments were performed with three different concentrations of P-glucan (5, 10, and 20 mu g/mL), in wich only the highest dose showed mutagenic activity. In the antimutagenicity experiments, the same concentrations of P-glucan were combined with a mutagenic agent, methylmethane sulfonate, or 2-aminoanthracene, using four different treatment protocols: pre-treatment, simultaneous treatment (simple and with pre-incubation), and post-treatment. The results indicate that the CHO-kl cell line treated with MMS presented a chemopreventive activity for all the doses of P-glucan in the different treatment protocols, except for the lowest dose in post-treatment. When HTC cell line treated with MMS is analysed, a chemopreventive activity can be verified for the highest dose in both pre- and post-treatment. For the simple simultaneous treatment, the three doses demonstrated efficacy, while for the simultaneous treatment with pre-incubation only the intermediate concentration was effective. In HTC treated with 2AA both the lowest dose in the pre-treatment protocol and the post-treatment protocol did not show efficacy in preventing DNA damage. The evaluation of the different protocols and the damage decrease percentages observed suggest that P-glucan has both desmutagenic and bioantimutagenic activity. It is necessary, however, to note that efficacy and mechanism of action are subject to variation when compared the two cell lines, since in HTC, representing a drug-metabolizing system, this substance can show a diminished chemopreventive capacity. (c) 2006 Elsevier Ltd. All rights reserved.

Enhanced emission from Eu(III) beta-diketone complex combined with ether-type oxygen atoms of di-ureasil organic-inorganic hybrids

Organic-inorganic hybrids, named di-ureasils and described by polyether-based chains grafted to both ends to a siliceous backbone through urea cross linkages, were used as hosts for incorporation of the well-known coordination complex of trivalent europium (Eu3+) ions described by the formula [Eu(TTA)(3)(H2O)(2)] (where TTA stands for thenoyltrifluoroacetone). By comparing with Eu3+-doped di-ureasil without complex form the new materials prepared here enhanced the quantum efficiency for photoemission of Eu3+ ions. The enhancement can be explained by the coordination ability of the organic counterpart of the host structure which is strong enough to displace water molecules in [Eu(TTA)(3)(H2O)(2)] from the rare earth neighbourhood after the incorporation process. High intensity of Eu3+ emission was observed with a low non-radiative decay rate under ultraviolet excitation. The quantum efficiency calculated from the decay of D-5(0) emission was 74%, which in the same range of values previously obtained for the most efficient Eu3+ coordination compounds reported in literature. Luminescence, X-ray absorption and infrared absorption results considered together leads to a picture where the first coordination shell of Eu3+ is composed of the 6 oxygen atoms of the 3 beta-diketonate ligands and 2 ether-like oxygen atoms of the host. (C) 2003 Elsevier B.V. B.V. All rights reserved.

Caratterizzazione dinamica sperimentale del rinforzo di pavimentazioni stradali con geogriglie tramite box test

Nella presente tesi viene affrontato il comportamento di materiali granulari sotto carico dinamico. In particolare, viene presentata la sperimentazione di laboratorio seguita presso il Nottingham Transportation Engineering Centre dell'Università di Nottingham, la costruzione del box test e le prove dinamiche eseguite sul materiale granulare rinforzato e non.

Triggers per attività di test su fascio di particelle. Realizzazione di un progetto in VHDL e sintetizzazione su FPGA

Progettazione e realizzazione di un dispositivo elettronico con lo scopo di coordinare e sincronizzare la presa dati del beam test del LUCID (CERN, luglio 2009) e tener traccia di tali eventi. Il circuito è stato progettato in linguaggio VHDL, simulato con il programma ModelSim, sintetizzato con il programma Quartus e implementato su un FPGA Cyclone residente su scheda di tipo VME 6U della CAEN. Infine la scheda è stata testata in laboratorio (verificandone il corretto funzionamento) assieme all'intero sistema di presa dati, e confermata per il beam test del LUCID.

Sviluppo di metodologie di localizzazione nel contesto del Comprehensive Nuclear Test-Ban Treaty

Since the first underground nuclear explosion, carried out in 1958, the analysis of seismic signals generated by these sources has allowed seismologists to refine the travel times of seismic waves through the Earth and to verify the accuracy of the location algorithms (the ground truth for these sources was often known). Long international negotiates have been devoted to limit the proliferation and testing of nuclear weapons. In particular the Treaty for the comprehensive nuclear test ban (CTBT), was opened to signatures in 1996, though, even if it has been signed by 178 States, has not yet entered into force, The Treaty underlines the fundamental role of the seismological observations to verify its compliance, by detecting and locating seismic events, and identifying the nature of their sources. A precise definition of the hypocentral parameters represents the first step to discriminate whether a given seismic event is natural or not. In case that a specific event is retained suspicious by the majority of the State Parties, the Treaty contains provisions for conducting an on-site inspection (OSI) in the area surrounding the epicenter of the event, located through the International Monitoring System (IMS) of the CTBT Organization. An OSI is supposed to include the use of passive seismic techniques in the area of the suspected clandestine underground nuclear test. In fact, high quality seismological systems are thought to be capable to detect and locate very weak aftershocks triggered by underground nuclear explosions in the first days or weeks following the test. This PhD thesis deals with the development of two different seismic location techniques: the first one, known as the double difference joint hypocenter determination (DDJHD) technique, is aimed at locating closely spaced events at a global scale. The locations obtained by this method are characterized by a high relative accuracy, although the absolute location of the whole cluster remains uncertain. We eliminate this problem introducing a priori information: the known location of a selected event. The second technique concerns the reliable estimates of back azimuth and apparent velocity of seismic waves from local events of very low magnitude recorded by a trypartite array at a very local scale. For the two above-mentioned techniques, we have used the crosscorrelation technique among digital waveforms in order to minimize the errors linked with incorrect phase picking. The cross-correlation method relies on the similarity between waveforms of a pair of events at the same station, at the global scale, and on the similarity between waveforms of the same event at two different sensors of the try-partite array, at the local scale. After preliminary tests on the reliability of our location techniques based on simulations, we have applied both methodologies to real seismic events. The DDJHD technique has been applied to a seismic sequence occurred in the Turkey-Iran border region, using the data recorded by the IMS. At the beginning, the algorithm was applied to the differences among the original arrival times of the P phases, so the cross-correlation was not used. We have obtained that the relevant geometrical spreading, noticeable in the standard locations (namely the locations produced by the analysts of the International Data Center (IDC) of the CTBT Organization, assumed as our reference), has been considerably reduced by the application of our technique. This is what we expected, since the methodology has been applied to a sequence of events for which we can suppose a real closeness among the hypocenters, belonging to the same seismic structure. Our results point out the main advantage of this methodology: the systematic errors affecting the arrival times have been removed or at least reduced. The introduction of the cross-correlation has not brought evident improvements to our results: the two sets of locations (without and with the application of the cross-correlation technique) are very similar to each other. This can be commented saying that the use of the crosscorrelation has not substantially improved the precision of the manual pickings. Probably the pickings reported by the IDC are good enough to make the random picking error less important than the systematic error on travel times. As a further justification for the scarce quality of the results given by the cross-correlation, it should be remarked that the events included in our data set don’t have generally a good signal to noise ratio (SNR): the selected sequence is composed of weak events ( magnitude 4 or smaller) and the signals are strongly attenuated because of the large distance between the stations and the hypocentral area. In the local scale, in addition to the cross-correlation, we have performed a signal interpolation in order to improve the time resolution. The algorithm so developed has been applied to the data collected during an experiment carried out in Israel between 1998 and 1999. The results pointed out the following relevant conclusions: a) it is necessary to correlate waveform segments corresponding to the same seismic phases; b) it is not essential to select the exact first arrivals; and c) relevant information can be also obtained from the maximum amplitude wavelet of the waveforms (particularly in bad SNR conditions). Another remarkable point of our procedure is that its application doesn’t demand a long time to process the data, and therefore the user can immediately check the results. During a field survey, such feature will make possible a quasi real-time check allowing the immediate optimization of the array geometry, if so suggested by the results at an early stage.

Studi ed approfondimenti sulla composizione in acidi grassi del latte bovino di razza Reggiana con diverso fenotipo per k-caseina e Beta-lactoglobulina

The aim of the present study was to examine the association between milk protein polymorphism and fatty acids profiles of bovine milk. Milk samples were collected from each of 55 Reggiana cows during early, mid and late lactation, respectively, in two farms within the production area of Parmigiano Reggiano cheese. Identification and quantification of fatty acids were performed by gas chromatography. Milk fatty acid composition using cows of differing κ-casein (κ-Cn) and β-lactoglobulin (β-Lg) phenotypes was investigated. Statistically significant results regarding the associations between milk fatty acid composition and κ-Cn phenotype were found, in particular, κ-Cn BB seems to influence de novo fatty acid synthesis in the mammary gland. Also κ-Cn AB seems to have the same effect. Proportions of C10:0 (2,29a AA; 2,53b AB; 2,59b BB), C12:0 (2,77a AA; 3,17b AB; 3,20b BB) and C14:0 (9,22a AA; 10,25b AB; 10,27b BB) were higher in the milk from cows with κ-Cn phenotype AB and BB vs κ-Cn phenotype AA (p<0,05). Conversely C18:0 (7,84b AA; 7,20a,b AB; 6,94a BB) and C18:1 (19,19b AA; 16,81a AB; 16,79a BB) were lower in the milk from cows with κ-Cn phenotype AB and BB vs κ-Cn phenotype AA. The association between milk fatty acid composition and β-Lg phenotype was not statistically significant, except for some fatty acids. In particular, C12:0 (3,05a AA; 3,04a AB; 3,33b BB) was higher in the milk from cows with β-Lg phenotype BB vs β-Lg phenotype AA and AB (p<0,05). Concentrations of C18:0 (6,93a AA; 7,86b AB; 6,59a BB) and C18:1 (16,74a,b AA; 18,24b AB; 16,07a BB) were lower in the milk from cows with β-Lg phenotype AA and BB vs β-Lg phenotype AB (p<0,05). Moreover this research, carried out in farms within the Parmigiano Reggiano cheese district, analysed also the size distribution of fat globules in bulk milk of Reggiana and Frisona breed cows. In particular, the size distribution of individual milk fat globules of Reggiana cows with differing κ-Cn phenotypes was considered. From first observations, no statistically significant differences were observed.

Design and synthesis of novel non peptidomimtic beta-secretase inhibitors in the treatment of Alzheimer's disease

The aspartic protease BACE1 (β-amyloid precursor protein cleaving enzyme, β-secretase) is recognized as one of the most promising targets in the treatment of Alzheimer's disease (AD). The accumulation of β-amyloid peptide (Aβ) in the brain is a major factor in the pathogenesis of AD. Aβ is formed by initial cleavage of β-amyloid precursor protein (APP) by β-secretase, therefore BACE1 inhibition represents one of the therapeutic approaches to control progression of AD, by preventing the abnormal generation of Aβ. For this reason, in the last decade, many research efforts have focused at the identification of new BACE1 inhibitors as drug candidates. Generally, BACE1 inhibitors are grouped into two families: substrate-based inhibitors, designed as peptidomimetic inhibitors, and non-peptidomimetic ones. The research on non-peptidomimetic small molecules BACE1 inhibitors remains the most interesting approach, since these compounds hold an improved bioavailability after systemic administration, due to a good blood-brain barrier permeability in comparison to peptidomimetic inhibitors. Very recently, our research group discovered a new promising lead compound for the treatment of AD, named lipocrine, a hybrid derivative between lipoic acid and the AChE inhibitor (AChEI) tacrine, characterized by a tetrahydroacridinic moiety. Lipocrine is one of the first compounds able to inhibit the catalytic activity of AChE and AChE-induced amyloid-β aggregation and to protect against reactive oxygen species. Due to this interesting profile, lipocrine was also evaluated for BACE1 inhibitory activity, resulting in a potent lead compound for BACE1 inhibition. Starting from this interesting profile, a series of tetrahydroacridine analogues were synthesised varying the chain length between the two fragments. Moreover, following the approach of combining in a single molecule two different pharmacophores, we designed and synthesised different compounds bearing the moieties of known AChEIs (rivastigmine and caproctamine) coupled with lipoic acid, since it was shown that dithiolane group is an important structural feature of lipocrine for the optimal inhibition of BACE1. All the tetrahydroacridines, rivastigmine and caproctamine-based compounds, were evaluated for BACE1 inhibitory activity in a FRET (fluorescence resonance energy transfer) enzymatic assay (test A). With the aim to enhancing the biological activity of the lead compound, we applied the molecular simplification approach to design and synthesize novel heterocyclic compounds related to lipocrine, in which the tetrahydroacridine moiety was replaced by 4-amino-quinoline or 4-amino-quinazoline rings. All the synthesized compounds were also evaluated in a modified FRET enzymatic assay (test B), changing the fluorescent substrate for enzymatic BACE1 cleavage. This test method guided deep structure-activity relationships for BACE1 inhibition on the most promising quinazoline-based derivatives. By varying the substituent on the 2-position of the quinazoline ring and by replacing the lipoic acid residue in lateral chain with different moieties (i.e. trans-ferulic acid, a known antioxidant molecule), a series of quinazoline derivatives were obtained. In order to confirm inhibitory activity of the most active compounds, they were evaluated with a third FRET assay (test C) which, surprisingly, did not confirm the previous good activity profiles. An evaluation study of kinetic parameters of the three assays revealed that method C is endowed with the best specificity and enzymatic efficiency. Biological evaluation of the modified 2,4-diamino-quinazoline derivatives measured through the method C, allow to obtain a new lead compound bearing the trans-ferulic acid residue coupled to 2,4-diamino-quinazoline core endowed with a good BACE1 inhibitory activity (IC50 = 0.8 mM). We reported on the variability of the results in the three different FRET assays that are known to have some disadvantages in term of interference rates that are strongly dependent on compound properties. The observed results variability could be also ascribed to different enzyme origin, varied substrate and different fluorescent groups. The inhibitors should be tested on a parallel screening in order to have a more reliable data prior to be tested into cellular assay. With this aim, preliminary cellular BACE1 inhibition assay carried out on lipocrine confirmed a good cellular activity profile (EC50 = 3.7 mM) strengthening the idea to find a small molecule non-peptidomimetic compound as BACE1 inhibitor. In conclusion, the present study allowed to identify a new lead compound endowed with BACE1 inhibitory activity in submicromolar range. Further lead optimization to the obtained derivative is needed in order to obtain a more potent and a selective BACE1 inhibitor based on 2,4-diamino-quinazoline scaffold. A side project related to the synthesis of novel enzymatic inhibitors of BACE1 in order to explore the pseudopeptidic transition-state isosteres chemistry was carried out during research stage at Università de Montrèal (Canada) in Hanessian's group. The aim of this work has been the synthesis of the δ-aminocyclohexane carboxylic acid motif with stereochemically defined substitution to incorporating such a constrained core in potential BACE1 inhibitors. This fragment, endowed with reduced peptidic character, is not known in the context of peptidomimetic design. In particular, we envisioned an alternative route based on an organocatalytic asymmetric conjugate addition of nitroalkanes to cyclohexenone in presence of D-proline and trans-2,5-dimethylpiperazine. The enantioenriched obtained 3-(α-nitroalkyl)-cyclohexanones were further functionalized to give the corresponding δ-nitroalkyl cyclohexane carboxylic acids. These intermediates were elaborated to the target structures 3-(α-aminoalkyl)-1-cyclohexane carboxylic acids in a new readily accessible way.